SC
DMTK

Savant Capital’s DermTech, Inc. Common Stock DMTK Stock Holding History

Savant Capital’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-35,184
Closed -$61.6K – 1130
2023
Q4 		$61.6K Buy
+35,184
New +$51.4K ﹤0.01% 835

Other funds holding DMTK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Woodmont Investment Counsel Nashville, Tennessee $1.62B AUM 18.92% 1-Year Est. Return

Savant Capital's DMTK Position: Q1 2024 in Review

Savant Capital sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2024, closing a stake of 35,184 shares — an estimated $61.6K sold.

Savant Capital first reported a position in DMTK in Q4 2023 and held it in 1 quarter. The position peaked at $61.6K in Q4 2023. 69 funds tracked by Wall St. Rank hold DMTK as of Q1 2024.

  • Savant Capital reported no remaining DermTech, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Savant Capital sold 35,184 DermTech, Inc. Common Stock shares in Q1 2024, an estimated $61.6K.
  • Savant Capital first reported a position in DermTech, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Savant Capital's DermTech, Inc. Common Stock position peaked at $61.6K in Q4 2023.
  • 69 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2024.

Based on Savant Capital's 13F filing for Q1 2024, filed 6 May 2024.